Incheon, South Korea

San Ha Son

USPTO Granted Patents = 3 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Mind of San Ha Son

Introduction

San Ha Son is a prominent inventor based in Incheon, South Korea, known for his groundbreaking work in biotechnology. With a total of two patents to his name, he has made significant contributions to the field, particularly in developing compounds that target specific proteins involved in various diseases.

Latest Patents

San Ha Son's latest patents include "Benzimidazole thiophene derivative compounds inducing selective degradation of PLK1" and "PLK1 selective degradation inducing compound." Both inventions spotlight novel compounds designed to induce the selective degradation of polo-like kinase 1 (PLK1). These bifunctional compounds link a PLK1 binding moiety with an E3 ubiquitin ligase-binding moiety via a chemical linker. This innovative approach has strong potential for preventing or treating diseases associated with PLK1, opening up new therapeutic avenues in molecular medicine.

Career Highlights

San Ha Son currently works with Uppthera, a company engaged in advanced biotechnology research. His work emphasizes the importance of targeted therapies and molecular innovation, which is pivotal in addressing specific medical needs. The recognition of his patents further underscores his role in advancing scientific knowledge and practical applications in the medical field.

Collaborations

In his quest for innovation, San Ha Son collaborates with notable colleagues, including Si Woo Choi and Soo Hee Ryu. Together, they contribute to a vibrant research environment that fosters creativity and scientific discovery. These collaborations enhance the research output at Uppthera and underline the team's commitment to advancing healthcare through innovative solutions.

Conclusion

San Ha Son stands out as a leading inventor whose work is poised to impact the field of biotechnology significantly. His innovative patents related to PLK1 degradation compounds reflect his dedication to addressing important health challenges. With a strong support network of colleagues and an environment that nurtures innovation, San Ha Son is set to continue making strides in the world of scientific research and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…